This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Cytlimic Inc., Nec Corporation. Active years: 2017-2023.
Company Filing History:
Years Active: 2017-2023
Title: Shun Doi: Innovator in Cancer Treatment
Introduction
Shun Doi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for cancer. With a total of 5 patents to his name, Doi's work is paving the way for new therapeutic approaches.
Latest Patents
Doi's latest patents include a medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein. This invention provides a medicine comprising a Toll-like receptor agonist, LAG-3 protein, or a variant or derivative thereof. Another notable patent is a composition comprising poly I:C and LAG-3-IGG fusion protein, which also focuses on a medicine containing a Toll-like receptor agonist and LAG-3 protein.
Career Highlights
Throughout his career, Shun Doi has worked with several notable companies, including Cytlimic Inc. and NEC Corporation. His experience in these organizations has contributed to his expertise in the field of medical innovations.
Collaborations
Doi has collaborated with esteemed colleagues such as Tomoya Miyakawa and Koji Tamada. Their joint efforts have further advanced the research and development of cancer treatments.
Conclusion
Shun Doi's contributions to cancer treatment through his innovative patents and collaborations highlight his importance in the medical field. His work continues to inspire advancements in therapeutic solutions for patients.